http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-106995440-B
Outgoing Links
Predicate | Object |
---|---|
classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D417-04 |
classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-444 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P13-12 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D417-04 |
filingDate | 2017-05-26-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
grantDate | 2019-09-03-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationDate | 2019-09-03-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber | CN-106995440-B |
titleOfInvention | 1- pyridine -6- methoxyl group -9- (2,3,4,5- ptfe benzyl) 'Beta '-carboline compound and its synthetic method and application |
abstract | The present invention relates to a kind of 'Beta '-carboline compound and its synthetic method and applications, belong to pharmaceutical technology field.The compound structure is shown in formula I, shows that the anti-kidney fibrosis activity of the Compound ira vitro is significant through preliminary experiment, has preferable potential medical value, can be used for the preparation of various anti-kidney fibrosis, anti-chronic kidney disease drug. |
priorityDate | 2017-05-26-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 67.